Many
existing clinical treatments are limited in their ability
to completely restore decreased or lost tissue and organ function,
an unenviable situation only further exacerbated by a globally aging
population. As a result, the demand for new medical interventions
has increased substantially over the past 20 years, with the burgeoning
fields of gene therapy, tissue engineering, and regenerative medicine
showing promise to offer solutions for full repair or replacement
of damaged or aging tissues. Success in these fields, however, inherently
relies on biomaterials that are engendered with the ability to provide
the necessary biological cues mimicking native extracellular matrixes
that support cell fate. Accelerating the development of such “directive”
biomaterials requires a shift in current design practices toward those
that enable rapid synthesis and characterization of polymeric materials
and the coupling of these processes with techniques that enable similarly
rapid quantification and optimization of the interactions between
these new material systems and target cells and tissues. This manuscript
reviews recent advances in combinatorial and high-throughput (HT)
technologies applied to polymeric biomaterial synthesis, fabrication,
and chemical, physical, and biological screening with targeted end-point
applications in the fields of gene therapy, tissue engineering, and
regenerative medicine. Limitations of, and future opportunities for,
the further application of these research tools and methodologies
are also discussed.